Scaffold-Hopping Cascade Yields Potent Inhibitors of 5-Lipoxygenase

被引：32

作者：

Hofmann, Bettina ^{[1
]}

Franke, Lutz ^{[1
]}

Proschak, Ewgenij ^{[1
]}

Tanrikulu, Yusuf ^{[1
]}

Schneider, Petra ^{[2
]}

Steinhilber, Dieter ^{[3
]}

Schneider, Gisbert ^{[1
]}

机构：

[1] Univ Frankfurt, Inst Organ Chem & Chem Biol, ZAFES CMP, D-60323 Frankfurt, Germany

[2] Schneider Consulting GbR, D-61440 Oberursel, Germany

[3] Univ Frankfurt, Inst Pharmaceut Chem, ZAFES, D-60438 Frankfurt, Germany

来源：

CHEMMEDCHEM | 2008年 / 3卷 / 10期

关键词：

bioisosters; cheminformatics; drug discovery; inflammation; virtual screening;

D O I：

10.1002/cmdc.200800153

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

(Chemical Equation Presented) A two-step iterative approach to virtual screening can identifypotent lead scaffolds as demonstrated for 5-lipoxygenase inhibition, a validated target for the treatment of inflammation and allergic reactions. Four cycles of virtual screening using both 3D- and 2D-based methods, and substructure searching were performed, and cell-based assays were used to further refine the lead selection at each stage of the process. © 2008 Wiley-VCH Verlag GmbH & Co. KGaA.

引用

页码：1535 / 1538

页数：4

共 50 条

[31] Therapeutic options for 5-lipoxygenase inhibitors
Werz, Oliver
Steinhilber, Dieter
PHARMACOLOGY & THERAPEUTICS, 2006, 112 (03) : 701 - 718
[32] DIPYRIDAMOLE - A POTENT AND SPECIFIC 5-LIPOXYGENASE INHIBITOR
CARTER, GW
DYER, R
YOUNG, P
FEDERATION PROCEEDINGS, 1985, 44 (04) : 904 - 904
[33] 5-Lipoxygenase inhibitors induce potent anti-proliferative and cytotoxic effects in human tumour cells independently of suppression of 5-lipoxygenase activity
Fischer, A. S.
Metzner, J.
Steinbrink, S. D.
Ulrich, S.
Angioni, C.
Geisslinger, G.
Steinhilber, D.
Maier, T. J.
BRITISH JOURNAL OF PHARMACOLOGY, 2010, 161 (04) : 936 - 949
[34] CONVERSION OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS INTO EITHER DUAL INHIBITORS OF 5-LIPOXYGENASE AND CYCLOOXYGENASE OR INTO SELECTIVE INHIBITORS OF 5-LIPOXYGENASE
BOSCHELLI, DH
CONNOR, DT
BORNEMEIER, DA
DYER, RD
KUIPERS, PJ
WRIGHT, CD
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1992, 203 : 123 - MEDI
[35] STUDIES ON THE SYNTHESIS OF 5-LIPOXYGENASE INHIBITORS
SHIRAISHI, M
KATO, K
OHKAWA, S
TERAO, S
JOURNAL OF PHARMACOBIO-DYNAMICS, 1984, 7 (05): : S95 - S95
[36] HYDROXAMIC ACID INHIBITORS OF 5-LIPOXYGENASE
SUMMERS, JB
MAZDIYASNI, H
HOLMS, JH
RATAJCZYK, JD
DYER, RD
CARTER, GW
JOURNAL OF MEDICINAL CHEMISTRY, 1987, 30 (03) : 574 - 580
[37] Inhibitors of the 5-Lipoxygenase Pathway in Atherosclerosis
Back, Magnus
CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (27) : 3116 - 3132
[38] A Scaffold-Hopping Strategy toward the Identification of Inhibitors of Cyclin G Associated Kinase
Wouters, Randy
Tian, Junjun
Herdewijn, Piet
De Jonghe, Steven
CHEMMEDCHEM, 2019, 14 (02) : 237 - 254
[39] Development of new HO-1 inhibitors by a thorough scaffold-hopping analysis
Floresta, Giuseppe
Pittala, Valeria
Sorrenti, Valeria
Romeo, Giuseppe
Salerno, Loredana
Rescifina, Antonio
BIOORGANIC CHEMISTRY, 2018, 81 : 334 - 339
[40] Discovery of Highly Potent Dual Orexin Receptor Antagonists via a Scaffold-Hopping Approach
Heidmann, Bibia
Gatfield, John
Roch, Catherine
Treiber, Alexander
Tortoioli, Simone
Brotschi, Christine
Williams, Jodi T.
Bolli, Martin H.
Abele, Stefan
Sifferlen, Thierry
Jenck, Francois
Boss, Christoph
CHEMMEDCHEM, 2016, 11 (19) : 2132 - 2146

← 1 2 3 4 5 →